DRL recalls Rivastigmine Tartrate capsules from US
A total of 60 bottles of 2952 units are recalled on the direction of US FDA
Author
US FDA warning letter to have no material impact on Mylan biz: CEO
Company claims to make important progress on FDA's observations
US FDA approves first treatment for sexual desire disorder
Addyi approved to treat premenopausal women
Aurobindo Pharma receives US FDA approval for Omeprazole delayed-release capsules
Omeprazole delayed-release capsules are indicated for short-term treatment of active duodenal ulcer in adults
US FDA approves Sun Pharma’s Ximino capsules
Ximino extended-release capsules are indicated for inflammatory lesions of non-nodular moderate to severe acne vulgaris in…
Mobile application on HIV/AIDS launched
Mobile application will provide complete information on HIV, increase awareness and risk perception as well as prompt users to…
Govt likely to set up think tank to solve pharma sector issues
The think tank likely to be set up within the next two months
Aspirin lowers risk of cancer in overweight people: Study
Being overweight more than doubled the risk of bowel cancer in people with Lynch Syndrome, an inherited genetic disorder which…
OPPI concludes 4th Healthcare Access Summit in Mumbai
Healthcare Access Award 2015 announced
Claris receives PAS for Furosemide injection in US
The company had received the original approval for this ANDA in January 2014 and was selling the products in the US in 2014